vs
Side-by-side financial comparison of Ouster, Inc. (OUST) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $62.2M, roughly 1.2× Ouster, Inc.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs 31.3%).
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
OUST vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.2M | $75.5M |
| Net Profit | — | — |
| Gross Margin | 60.2% | 69.3% |
| Operating Margin | 1.5% | 22.7% |
| Net Margin | — | — |
| Revenue YoY | 106.6% | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.10 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.2M | $75.5M | ||
| Q3 25 | $39.5M | $54.5M | ||
| Q2 25 | $35.0M | $52.4M | ||
| Q1 25 | $32.6M | $46.0M | ||
| Q4 24 | $30.1M | $59.1M | ||
| Q3 24 | $28.1M | $80.5M | ||
| Q2 24 | $27.0M | $47.1M | ||
| Q1 24 | $25.9M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-21.7M | $8.8M | ||
| Q2 25 | $-20.6M | $5.9M | ||
| Q1 25 | $-22.0M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-25.6M | $20.3M | ||
| Q2 24 | $-23.9M | $-4.5M | ||
| Q1 24 | $-23.8M | $-4.8M |
| Q4 25 | 60.2% | 69.3% | ||
| Q3 25 | 42.1% | 77.7% | ||
| Q2 25 | 45.2% | 76.5% | ||
| Q1 25 | 41.3% | 77.1% | ||
| Q4 24 | 43.8% | 76.4% | ||
| Q3 24 | 38.3% | 63.9% | ||
| Q2 24 | 33.7% | 77.4% | ||
| Q1 24 | 28.6% | 75.5% |
| Q4 25 | 1.5% | 22.7% | ||
| Q3 25 | -61.4% | 17.6% | ||
| Q2 25 | -76.5% | 12.7% | ||
| Q1 25 | -73.0% | 8.7% | ||
| Q4 24 | -85.1% | 22.6% | ||
| Q3 24 | -98.0% | 27.4% | ||
| Q2 24 | -93.6% | -4.6% | ||
| Q1 24 | -99.5% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -55.0% | 16.2% | ||
| Q2 25 | -58.8% | 11.2% | ||
| Q1 25 | -67.5% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -91.1% | 25.2% | ||
| Q2 24 | -88.4% | -9.6% | ||
| Q1 24 | -91.9% | -11.0% |
| Q4 25 | $0.10 | $0.26 | ||
| Q3 25 | $-0.37 | $0.17 | ||
| Q2 25 | $-0.38 | $0.12 | ||
| Q1 25 | $-0.42 | $0.06 | ||
| Q4 24 | $-0.46 | $0.40 | ||
| Q3 24 | $-0.54 | $0.41 | ||
| Q2 24 | $-0.53 | $-0.09 | ||
| Q1 24 | $-0.55 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $208.6M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $261.7M | $130.3M |
| Total Assets | $349.5M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $208.6M | $97.5M | ||
| Q3 25 | $244.5M | $94.4M | ||
| Q2 25 | $226.5M | $96.0M | ||
| Q1 25 | $168.2M | $93.2M | ||
| Q4 24 | $172.0M | $101.0M | ||
| Q3 24 | $151.4M | $96.7M | ||
| Q2 24 | $184.2M | $96.8M | ||
| Q1 24 | $187.8M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $261.7M | $130.3M | ||
| Q3 25 | $247.4M | $115.3M | ||
| Q2 25 | $221.0M | $104.7M | ||
| Q1 25 | $167.9M | $97.1M | ||
| Q4 24 | $180.9M | $92.1M | ||
| Q3 24 | $171.7M | $71.1M | ||
| Q2 24 | $170.6M | $48.5M | ||
| Q1 24 | $167.2M | $51.0M |
| Q4 25 | $349.5M | $216.3M | ||
| Q3 25 | $353.8M | $202.9M | ||
| Q2 25 | $321.8M | $194.9M | ||
| Q1 25 | $268.6M | $196.2M | ||
| Q4 24 | $276.1M | $213.3M | ||
| Q3 24 | $255.2M | $220.7M | ||
| Q2 24 | $309.9M | $205.0M | ||
| Q1 24 | $317.7M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.4M | $14.4M |
| Free Cash FlowOCF − Capex | $-37.2M | $14.4M |
| FCF MarginFCF / Revenue | -59.8% | 19.1% |
| Capex IntensityCapex / Revenue | 35.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-64.8M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.4M | $14.4M | ||
| Q3 25 | $-18.3M | $9.7M | ||
| Q2 25 | $-1.3M | $14.1M | ||
| Q1 25 | $-4.9M | $3.6M | ||
| Q4 24 | $-2.6M | $15.6M | ||
| Q3 24 | $-3.8M | $11.0M | ||
| Q2 24 | $-21.6M | $1.0M | ||
| Q1 24 | $-5.7M | $11.2M |
| Q4 25 | $-37.2M | $14.4M | ||
| Q3 25 | $-20.0M | $9.7M | ||
| Q2 25 | $-2.2M | $14.1M | ||
| Q1 25 | $-5.4M | $3.6M | ||
| Q4 24 | $-4.0M | $15.6M | ||
| Q3 24 | $-4.3M | $11.0M | ||
| Q2 24 | $-22.0M | $1.0M | ||
| Q1 24 | $-7.1M | — |
| Q4 25 | -59.8% | 19.1% | ||
| Q3 25 | -50.7% | 17.7% | ||
| Q2 25 | -6.3% | 26.8% | ||
| Q1 25 | -16.6% | 7.7% | ||
| Q4 24 | -13.3% | 26.4% | ||
| Q3 24 | -15.4% | 13.7% | ||
| Q2 24 | -81.5% | 2.1% | ||
| Q1 24 | -27.4% | — |
| Q4 25 | 35.0% | 0.0% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 2.5% | 0.0% | ||
| Q1 25 | 1.7% | 0.1% | ||
| Q4 24 | 4.8% | 0.0% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | 5.3% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
